“Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2”
Lopez, et al. Neuron, Volume 110, Issue 14, 20 July 2022, Pages 2283-2298.e9
The recent development of novel, fast acting, and durable antidepressant treatments such as Ketamine, Brexanolone, and Psilocybin has disrupted our view of the neuroscience and treatment of mood disorders. The Rapid Antidepressants Journal Club focuses on the research into the basic and translational science of how these drugs work.
Full schedule, Rapid Antidepressants Journal Club
For inquiries contact Joshua Siegel.